期刊文献+

血小板反应素-1活性片段的克隆与表达

Cloning and Expression Active Fragments of Human Thrombospondin-1
在线阅读 下载PDF
导出
摘要 选择两段血小板反应素(TSP-1)中抑制血管再生的活性片段,设计两对引物,使用RT-PCR的方法从人血细胞中进行克隆并对获得片段进行测序验证.克隆片段大小分别为723和522bp,命名为TSP-1-1和TSP-1-2.利用原核表达载体pET-29a获得大肠杆菌重组子,重组子经过IPTG诱导以包涵体的形式表达相应的多肽片段.再对包涵体进行体外溶解、纯化,得到了目的多肽. Two pairs of primers were designed according to the sequence of human thrombospondin-1 (TSP-1). Two active fragments of TSP-1, called TSP-1-1 and TSP-1-2, were obtained by using reverse transcription-polymerase chainreaction (RT-PCR) from blood samples. The sizes of those two fragments were found to be 723bp and 522bp respectively. They were inserted into pET-29a vector to get E. coli recombinants. Target peptides were found in inclusion body after IPTG inducement. Dissolving inclusion body in PBS were got by soluble TSP-1-2 peptides.
出处 《四川大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第5期1047-1050,共4页 Journal of Sichuan University(Natural Science Edition)
关键词 血小板反应素-1 抗血管生成 克隆与表达 包涵体 Thrombospondin-1 anti-angiogenesis cloning and expression inclusion body
  • 相关文献

参考文献6

  • 1刘澎(综述),林忠朝(审校).凝血酶敏感蛋白1抗血管新生作用研究进展[J].国外医学(生理病理科学与临床分册),2002,22(2):122-124. 被引量:9
  • 2Tolsma S , Volpert O V, Good D J, et al. J.Cell Biol, 1993,122(2):475-511.
  • 3Iruela-Arispe M L, Lombardo M, Krutzsch H C, et al. Circulation,1999 ,100(13) :1423-1431.
  • 4沈先荣,吉冬梅,贾福星,胡幼卿,蒋定文,邓新贤,储智勇,王玲,雷呈祥,黄建生,胡忻然,任大明.一种新的血管生成抑制因子—TSF的设计及表达[J].中华航海医学与高气压医学杂志,2002,9(4):239-245. 被引量:3
  • 5DawsonDW, Volpert OV, PearceSFA, etal. Mol. Pharmacl, 1999,55(2);332-338.
  • 6Sambrook J, Fristsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual, 2ed[ M]. New York: Cold Spring Harbor Laboratory Press, 1989. 825 - 826.

二级参考文献35

  • 1Gupta SK, Hassel T, Singh JP. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci USA, 1995,92:7799-7804.
  • 2Maione TE, Gray GS, Petro J, et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.Science, 1990,247: 77-80.
  • 3Debra LWS, Vivian SZ, Kenneth V, et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Research, 1994,54: 6504-6511.
  • 4Sara ST, Olga VV, Deborah JG, et al. Peptides derived from two separate domains of the matrix protein thrombospondin-1have anti-angiogenic activity. J Cell Biol, 1993,122: 497- 503.
  • 5Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, 1989. 1847-1858.
  • 6Mosmann T. Rapid Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immuno Met, 1983,65: 55-63.
  • 7Good DJ, Polverini PJ, Rastinejad F, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA, 1990,87:6624-6628.
  • 8Grossfelt GD, Ginsberg GA, Stern JP. Thrombospond-1 expression in bladder cancer :association with 53P alterations, tumor angiogenesis, and tumor progress. J Natl Cancer Inst (Bethesda), 1997,89: 219-225.
  • 9Gupta SK, Singh JP. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J Cell Bio1,1994,127:1121-1127.
  • 10Tanaka T, Manome Y, Wen P, et al. Viral vector-mediated transduction of a modified platelet factor 4 eDNA inhibits angiogenesis and tumor growth. Nature Med, 1997,3: 437-442.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部